SCHEMBL30906528

CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O

nearest known ligand 0.64

Predicted protein targets (top 4)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	17/20	0.63

▸	CCKBR	P32239	2/20	0.63

▸	C5AR1	P21730	2/20	0.63

▸	GCGR	P47871	3/20	0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906445	0.96	GLP1R (0.63)	GLP1RCCKBRGCGR
SCHEMBL30906405	0.95	GLP1R (0.62)	GLP1RCCKBRGCGR
SCHEMBL30906544	0.94	GLP1R (0.62)	GLP1RCCKBRC5AR1GCGR
SCHEMBL31099270	0.89	GLP1R (0.75)	GLP1RCCKBRGCGR
SCHEMBL31099252	0.89	GLP1R (0.75)	GLP1RCCKBRGCGR
SCHEMBL30906343	0.89	GLP1R (0.65)	GLP1RCCKBRC5AR1GCGR
SCHEMBL30906418	0.89	NPY1R (0.57)	GLP1R
SCHEMBL31182561	0.89	GLP1R (0.68)	GLP1RCCKBRGCGR
SCHEMBL31402801	0.88	C5AR1 (0.71)	GLP1RCCKBRC5AR1GCGR
SCHEMBL31547375	0.88	NPY2R (0.71)	GLP1RCCKBRC5AR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed